Literature DB >> 10419525

Functional analysis of the N-terminal CXXC metal-binding motifs in the human Menkes copper-transporting P-type ATPase expressed in cultured mammalian cells.

I Voskoboinik1, D Strausak, M Greenough, H Brooks, M Petris, S Smith, J F Mercer, J Camakaris.   

Abstract

The Menkes protein (MNK) is a copper-transporting P-type ATPase, which has six highly conserved metal-binding sites, GMTCXXC, at the N terminus. The metal-binding sites may be involved in MNK trafficking and/or copper-translocating activity. In this study, we report the detailed functional analysis in mammalian cells of recombinant human MNK and its mutants with various metal-binding sites altered by site-directed mutagenesis. The results of the study, both in vitro and in vivo, provide evidence that the metal-binding sites of MNK are not essential for the ATP-dependent copper-translocating activity of MNK. Moreover, metal-binding site mutations, which resulted in a loss of ability of MNK to traffick to the plasma membrane, produced a copper hyperaccumulating phenotype. Using an in vitro vesicle assay, we demonstrated that the apparent K(m) and V(max) values for the wild type MNK and its mutants were not significantly different. The results of this study suggest that copper-translocating activity of MNK and its copper-induced relocalization to the plasma membrane represent a well coordinated copper homeostasis system. It is proposed that mutations in MNK which alter either its catalytic activity or/and ability to traffick can be the cause of Menkes disease.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10419525     DOI: 10.1074/jbc.274.31.22008

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  31 in total

1.  A novel histidine-rich CPx-ATPase from the filamentous cyanobacterium Oscillatoria brevis related to multiple-heavy-metal cotolerance.

Authors:  Liu Tong; Susumu Nakashima; Mineo Shibasaka; Maki Katsuhara; Kunihiro Kasamo
Journal:  J Bacteriol       Date:  2002-09       Impact factor: 3.490

2.  CopA: An Escherichia coli Cu(I)-translocating P-type ATPase.

Authors:  C Rensing; B Fan; R Sharma; B Mitra; B P Rosen
Journal:  Proc Natl Acad Sci U S A       Date:  2000-01-18       Impact factor: 11.205

Review 3.  Cellular multitasking: the dual role of human Cu-ATPases in cofactor delivery and intracellular copper balance.

Authors:  Svetlana Lutsenko; Arnab Gupta; Jason L Burkhead; Vesna Zuzel
Journal:  Arch Biochem Biophys       Date:  2008-05-21       Impact factor: 4.013

Review 4.  Structural biology of copper trafficking.

Authors:  Amie K Boal; Amy C Rosenzweig
Journal:  Chem Rev       Date:  2009-10       Impact factor: 60.622

Review 5.  Copper metallochaperones.

Authors:  Nigel J Robinson; Dennis R Winge
Journal:  Annu Rev Biochem       Date:  2010       Impact factor: 23.643

Review 6.  ATP7A-related copper transport diseases-emerging concepts and future trends.

Authors:  Stephen G Kaler
Journal:  Nat Rev Neurol       Date:  2011-01       Impact factor: 42.937

7.  ATP7A trafficking and mechanisms underlying the distal motor neuropathy induced by mutations in ATP7A.

Authors:  Ling Yi; Stephen Kaler
Journal:  Ann N Y Acad Sci       Date:  2014-04-22       Impact factor: 5.691

Review 8.  Molecular pathogenesis of Wilson and Menkes disease: correlation of mutations with molecular defects and disease phenotypes.

Authors:  P de Bie; P Muller; C Wijmenga; L W J Klomp
Journal:  J Med Genet       Date:  2007-08-23       Impact factor: 6.318

Review 9.  Menkes copper-translocating P-type ATPase (ATP7A): biochemical and cell biology properties, and role in Menkes disease.

Authors:  Ilia Voskoboinik; James Camakaris
Journal:  J Bioenerg Biomembr       Date:  2002-10       Impact factor: 2.945

10.  An NMR study of the interaction of the N-terminal cytoplasmic tail of the Wilson disease protein with copper(I)-HAH1.

Authors:  Lucia Banci; Ivano Bertini; Francesca Cantini; Chiara Massagni; Manuele Migliardi; Antonio Rosato
Journal:  J Biol Chem       Date:  2009-01-30       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.